Skip to main content
SpringerLink
Log in

FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome

  • Original Investigation
  • Published:
Human Genetics Aims and scope Submit manuscript

Abstract

Rearrangements in the distal region of the short arm of chromosome 1 are recurrent aberrations in a broad spectrum of human neoplasias. However, neither the location of the breakpoints (BP) on 1p36 nor the candidate genes have been fully determined. We have characterized, by fluorescence in situ hybridization (FISH), the BP in 26 patients with hematological neoplasias and 1p36 rearrangements in the G-banding karyotype. FISH allowed a better characterization of all samples analyzed. Nine cases (35%) showed reciprocal translocations, 15 (58%) unbalanced rearrangements, and two (7%) deletions. We describe two new recurrent aberrations. In 18 of the 26 cases analyzed the BP were located in band 1p36, which is 25.5 Mb long. In 14 of these 18 cases (78%) and without distinction between myeloid and lymphoid neoplasias, the BP clustered in a 2.5 Mb region located between 1p36.32 and the telomere. Interestingly, this region is contained in the 10.5 Mb cluster on 1p36.22-1pter defined in cases with 1p36 deletion syndrome. The 2.5 Mb region, located on 1p36.32-1pter, has a higher frequency of occurrence of tandem repeats and segmental duplications larger than 1 kb, when compared with the 25.5 Mb of the complete 1p36 band. This could explain its proneness for involvement in chromosomal rearrangements in hematological neoplasias.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  • Atkin NB (1986) Chromosome 1 aberrations in cancer. Cancer Genet Cytogenet 21:279–285

    Google Scholar 

  • Bader SA, Fasching C, Brodeur GM, Stanbridge EJ (1991) Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth Differ 2:245–255

    Google Scholar 

  • Bailey JA, Yavor AM, Massa HF, Trask BJ, Eichler EE (2001) Segmental duplications: organization and impact within the current human genome project assembly. Genome Res 11:1005–1017

    Google Scholar 

  • Bauer A, Savelyeva L, Claas A, Praml C, Berthold F, Schwab M (2001) Smallest region of overlapping deletion in 1p36 in human neuroblastoma: a 1 Mbp cosmid and PAC contig. Genes Chromosomes Cancer 31:228–239

    Google Scholar 

  • Benson G (1999) Tandem repeats finder: a program to analyze DNA sequences. Nucleic Acids Res 27:573–580

    Article  CAS  PubMed  Google Scholar 

  • Boei JJ, Vermeulen S, Natarajan AT (1998) Dose-response curves for X-ray induced interchanges and interarm intrachanges in human lymphocytes using arm-specific probes for chromosome 1. Mutat Res 404:45–53

    Google Scholar 

  • Brodeur GM, Sekhon G, Goldstein MN (1977) Chromosomal aberrations in human neuroblastomas. Cancer 40:2256–2263

    Google Scholar 

  • Caron H, Sluis P van, Kraker J de, Bokkerink J, Egeler M, Laureys G, Slater R, Westerveld A, Voute PA, Versteeg R (1996) Allelic loss of chromosome 1p as a predictor of unfavorable outcome in patients with neuroblastoma. N Engl J Med 334:225–230

    Google Scholar 

  • Caron H, Spieker N, Godfried M, Veenstra M, Sluis P van, Kraker J de, Voute P, Versteeg R (2001) Chromosome bands 1p35-36 contain two distinct neuroblastoma tumor suppressor loci, one of which is imprinted. Genes Chromosomes Cancer 30:168–174

    Google Scholar 

  • Cheng NC, Van Roy N, Chan A, Beitsma M, Westerveld A, Speleman F, Versteeg R (1995) Deletion mapping in neuroblastoma cell lines suggests two distinct tumor suppressor genes in the 1p35–36 region, only one of which is associated with N-myc amplification. Oncogene 10:291–297

    Google Scholar 

  • Dave BJ, Hopwood VL, King TM, Jiang H, Spitz MR, Pathak S, Ziang H (1995) Genetic susceptibility to lung cancer as determined by lymphocytic chromosome analysis. Cancer Epidemiol Biomarkers Prev 4:743–749

    Google Scholar 

  • Dave BJ, Pickering DL, Hess MM, Weisenburger DD, Armitage JO, Sanger WG (1999) Deletion of cell division cycle 2-like 1 gene locus on 1p36 in non-Hodgkin lymphoma. Cancer Genet Cytogenet 108:120–126

    Google Scholar 

  • Gilbert F, Balaban G, Moorhead P, Bianchi D, Schlesinger H (1982) Abnormalities of chromosome 1p in human neuroblastoma tumors and cell lines. Cancer Genet Cytogenet 7:33–42

    Google Scholar 

  • Heilstedt HA, Ballif BC, Howard LA, Lewis RA, Stal S, Kashork CD, Bacino CA, Shapira SK, Shaffer LG (2003) Physical map of 1p36, placement of breakpoints in monosomy 1p36, and clinical characterization of the syndrome. Am J Hum Genet 72:1200–1212

    Article  CAS  PubMed  Google Scholar 

  • Hofmann WK, Takeuchi S, Xie D, Miller CW, Hoelzer D, Koeffler HP (2001) Frequent loss of heterozygosity in the region of D1S450 at 1p36.2 in myelodysplastic syndromes. Leuk Res 25:855–858

    Google Scholar 

  • Hubbard T, Barker D, Birney E, Cameron G, Chen Y, Clark L, Cox T, Cuff J, Curwen V, Down T, Durbin R, Eyras E, Gilbert J, Hammond M, Huminiecki L, Kasprzyk A, Lehvaslaiho H, Lijnzaad P, Melsopp C, Mongin E, Pettett R, Pocock M, Potter S, Rust A, Schmidt E, Searle S, Slater G, Smith J, Spooner W, Stabenau A, Stalker J, Stupka E, Ureta-Vidal A, Vastrik I, Clamp M (2002) The Ensembl genome database project. Nucleic Acids Res 30:38–41

    Article  CAS  PubMed  Google Scholar 

  • Inokuchi K, Hamaguchi H, Taniwaki M, Yamaguchi H, Tanosaki S, Dan K (2001) Establishment of a cell line with AML1-MTG8, TP53, and TP73 abnormalities from acute myelogenous leukemia. Genes Chromosomes Cancer 32:182–187

    Google Scholar 

  • Ji Y, Eichler EE, Schwartz S, Nicholls RD (2000) Structure of chromosomal duplicons and their role in mediating human genomic disorders. Genome Res 10:597–610

    Google Scholar 

  • Johansson B, Billstrom R, Broberg K, Fioretos T, Nilsson PG, Ahlgren T, Malm C, Samuelsson BO, Mitelman F (1999) Cytogenetic polyclonality in hematologic malignancies. Genes Chromosomes Cancer 24:222–229

    Google Scholar 

  • Jost CA, Marin MC, Kaelin WG Jr (1997) p73 is a simian [correction of human] p53-related protein that can induce apoptosis. Nature 389:191–194

    Google Scholar 

  • Lahortiga I, Agirre X, Belloni E, Vazquez I, Larrayoz MJ, Gasparini P, Coco FL, Pelicci PG, Calasanz MJ, Odero MD (2004) Molecular characterization of a t(1;3)(p36;q21) in a patient with MDS. MEL1 is widely expressed in normal tissues, including bone marrow, and it is not overexpressed in the t(1;3) cells. Oncogene 23:311–316

    Google Scholar 

  • Lestou VS, Ludkovski O, Connors JM, Gascoyne RD, Lam WL, Horsman DE (2003) Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis. Genes Chromosomes Cancer 36:375–381

    Google Scholar 

  • Levine EG, Arthur DC, Frizzera G, Peterson BA, Hurd DD, Bloomfield CD (1988) Cytogenetic abnormalities predict clinical outcome in non-Hodgkin lymphoma. Ann Intern Med 108:14–20

    Google Scholar 

  • Maris JM, Weiss MJ, Guo C, Gerbing RB, Stram DO, White PS, Hogarty MD, Sulman EP, Thompson PM, Lukens JN, Matthay KK, Seeger RC, Brodeur GM (2000) Loss of heterozygosity at 1p36 independently predicts for disease progression but not decreased overall survival probability in neuroblastoma patients: a Children’s Cancer Group study. J Clin Oncol 18:1888–1899

    Google Scholar 

  • Martinsson T, Sjoberg RM, Hedborg F, Kogner P (1995) Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms. Cancer Res 55:5681–5686

    Google Scholar 

  • Mitelman F (ed) (1995) ISCN (1995) An international system for human cytogenetic nomenclature. Karger, Basel

    Google Scholar 

  • Mitelman F (2000) Recurrent chromosome aberrations in cancer. Mutat Res 462:247–253

    Article  CAS  PubMed  Google Scholar 

  • Mitelman F, Mertens F, Johansson B (1997) A breakpoint map of recurrent chromosomal rearrangements in human neoplasia. Nat Genet 15:417–474

    Google Scholar 

  • Mitelman F, Johansson B, Mertens F (eds) (2003) Mitelman database of chromosome aberrations in cancer. http://cgap.nci.nih.gov/Chromosomes/Mitelman

  • Mori N, Morosetti R, Spira S, Lee S, Ben-Yehuda D, Schiller G, Landolfi R, Mizoguchi H, Koeffler HP (1998) Chromosome band 1p36 contains a putative tumor suppressor gene important in the evolution of chronic myelocytic leukemia. Blood 92:3405–3409

    Google Scholar 

  • Mori N, Morosetti R, Mizoguchi H, Koeffler HP (2003) Progression of myelodysplastic syndrome: allelic loss on chromosomal arm 1p. Br J Haematol 122:226–230

    Google Scholar 

  • Odero MD, Carlson K, Calasanz MJ, Lahortiga I, Chinwalla V, Rowley JD (2001) Identification of new translocations involving ETV6 in hematologic malignancies by fluorescence in situ hybridization and spectral karyotyping. Genes Chromosomes Cancer 31:134–142

    Google Scholar 

  • Odero MD, Vizmanos JL, Roman JP, Lahortiga I, Panizo C, Calasanz MJ, Zeleznik-Le NJ, Rowley JD, Novo FJ (2002) A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a patient with myelodysplastic syndrome. Genes Chromosomes Cancer 35:11–19

    Google Scholar 

  • Offit K, Wong G, Filippa DA, Tao Y, Chaganti RS (1991) Cytogenetic analysis of 434 consecutively ascertained specimens of non-Hodgkin’s lymphoma: clinical correlations. Blood 77:1508–1515

    Google Scholar 

  • Osborne LR, Li M, Pober B, Chitayat D, Bodurtha J, Mandel A, Costa T, Grebe T, Cox S, Tsui LC, Scherer SW (2001) A 1.5 million-base pair inversion polymorphism in families with Williams-Beuren syndrome. Nat Genet 29:321–325

    Google Scholar 

  • Pujana MA, Nadal M, Gratacos M, Peral B, Csiszar K, Gonzalez-Sarmiento R, Sumoy L, Estivill X (2001) Additional complexity on human chromosome 15q: identification of a set of newly recognized duplicons (LCR15) on 15q11–q13, 15q24, and 15q26. Genome Res 11:98–111

    Google Scholar 

  • Rice P, Longden I, Bleasby A (2000) EMBOSS: the European molecular biology open software suite. Trends Genet 16:276–277

    Article  CAS  PubMed  Google Scholar 

  • Rowley JD (1999) The role of chromosome translocations in leukemogenesis. Semin Hematol 36:59–72

    Google Scholar 

  • Saglio G, Storlazzi CT, Giugliano E, Surace C, Anelli L, Rege-Cambrin G, Zagaria A, Jimenez Velasco A, Heiniger A, Scaravaglio P, Torres Gomez A, Roman Gomez J, Archidiacono N, Banfi S, Rocchi M (2002) A 76-kb duplicon maps close to the BCR gene on chromosome 22 and the ABL gene on chromosome 9: possible involvement in the genesis of the Philadelphia chromosome translocation. Proc Natl Acad Sci USA 99:9882–9887

    Google Scholar 

  • Schutte BC, Carpten JD, Forus A, Gregory SG, Horii A, White PS (2001) Report and abstracts of the Sixth International Workshop on Human Chromosome 1 Mapping 2000, Iowa City, Iowa, USA 30 September-3 October 2000. Cytogenet Cell Genet 92:23–41

    Google Scholar 

  • Shaffer LG, Heilstedt HA (2001) Terminal deletion of 1p36. Lancet 358:S9

    Google Scholar 

  • Shapira SK, McCaskill C, Northrup H, Spikes AS, Elder FF, Sutton VR, Korenberg JR, Greenberg F, Shaffer LG (1997) Chromosome 1p36 deletions: the clinical phenotype and molecular characterization of a common newly delineated syndrome. Am J Hum Genet 61:642–650

    CAS  PubMed  Google Scholar 

  • Shimizu S, Suzukawa K, Kodera T, Nagasawa T, Abe T, Taniwaki M, Yagasaki F, Tanaka H, Fujisawa S, Johansson B, Ahlgren T, Yokota J, Morishita K (2000) Identification of breakpoint cluster regions at 1p36.3 and 3q21 in hematologic malignancies with t(1;3)(p36;q21). Genes Chromosomes Cancer 27:229–238

    Google Scholar 

  • Spieker N, Beitsma M, Van Sluis P, Chan A, Caron H, Versteeg R (2001) Three chromosomal rearrangements in neuroblastoma cluster within a 300-kb region on 1p36.1. Genes Chromosomes Cancer 31:172–181

    Google Scholar 

  • Varga AE, Dobrovic A, Webb GC, Hutchinson R (2001) Clustering of 1p36 breakpoints distal to 1p36.2 in hematological malignancies. Cancer Genet Cytogenet 125:78–79

    Google Scholar 

  • Weith A, Martinsson T, Cziepluch C, Bruderlein S, Amler LC, Berthold F, Schwab M (1989) Neuroblastoma consensus deletion maps to 1p36.1-2. Genes Chromosomes Cancer 1:159–166

    Google Scholar 

  • Weith A, Brodeur GM, Bruns GA, Matise TC, Mischke D, Nizetic D, Seldin MF, Roy N van, Vance J (1996) Report of the Second International Workshop on Human Chromosome 1 Mapping 1995. Cytogenet Cell Genet 72:114–144

    Google Scholar 

  • White PS, Maris JM, Beltinger C, Sulman E, Marshall HN, Fujimori M, Kaufman BA, Biegel JA, Allen C, Hilliard C, et al (1995) A region of consistent deletion in neuroblastoma maps within human chromosome 1p36.2-36.3. Proc Natl Acad Sci USA 92:5520–5524

    Google Scholar 

Download references

Acknowledgements

We thank Dr. Reiner Siebert and Dr. José Ignacio Martín Subero for helpful discussion, and Nekane Sanjosé and Carmen Ferreira for technical assistance. This work was supported by: Fundación Investigación Médica Aplicada and “UTE project CIMA”; Fundación Científica de la Asociación Española contra el Cáncer; Ministerio de Sanidad (FIS 01/0133), RTIC Cancer C10/03 (FIS); Fundación Internacional José Carreras (FIJC-03/ESP) (Spain) Eredità “Benilde Vidti”; and AIRC (Associazione Italiana per la Ricerca sul Cancro) (Italy).

Author information

Authors and Affiliations

  1. Laboratory of Genetics, Division of Oncology, Center for Applied Medical Research (CIMA), University of Navarra, Pio XII, 55, 31080, Pamplona, Spain

    Idoya Lahortiga, Iria Vázquez, Isabel Zudaire & María D. Odero

  2. Department of Genetics, School of Science, University of Navarra, Pamplona, Spain

    Iria Vázquez, José P. Román, Francisco J. Novo, María J. Calasanz & María D. Odero

  3. IFOM, Fondazione Istituto FIRC di Oncologia Molecolare, Milan, Italy

    Elena Belloni, Patrizia Gasparini & Pier G. Pelicci

  4. Instituto Europeo di Oncologia, Milan, Italy

    Elena Belloni, Patrizia Gasparini & Pier G. Pelicci

  5. Dipartimento di Medicina, Chirurgia ed Odontoiatria, Universita’ degli Studi di Milano, Milan, Italy

    Pier G. Pelicci

  6. Department of Hematology, Hospital Universitario& Centro de Investigación del Cáncer, University of Salamanca-CSIC, Salamanca, Spain

    Jesús M. Hernández

Authors
  1. Idoya Lahortiga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Iria Vázquez
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Elena Belloni
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. José P. Román
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Patrizia Gasparini
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Francisco J. Novo
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Isabel Zudaire
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Pier G. Pelicci
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jesús M. Hernández
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. María J. Calasanz
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. María D. Odero
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Idoya Lahortiga.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lahortiga, I., Vázquez, I., Belloni, E. et al. FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome. Hum Genet 116, 476–485 (2005). https://doi.org/10.1007/s00439-005-1268-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00439-005-1268-1

Keywords

Search

Navigation